CN105055781A - Traditional Chinese medicine composition for treating female infertility - Google Patents
Traditional Chinese medicine composition for treating female infertility Download PDFInfo
- Publication number
- CN105055781A CN105055781A CN201510540293.7A CN201510540293A CN105055781A CN 105055781 A CN105055781 A CN 105055781A CN 201510540293 A CN201510540293 A CN 201510540293A CN 105055781 A CN105055781 A CN 105055781A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- fructus
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating the female infertility. The traditional Chinese medicine composition comprises, by weight, 12 parts to 18 parts of codonopsis pilosula, 9 parts to 12 parts of bighead atractylodes rhizomes, 9 parts to 12 parts of poria cocos, 10 parts to 15 parts of radix paeoniae alba, 10 parts to 15 parts of angelica sinensis, 4 parts to 9 parts of ligusticum wallichii, 10 parts to 15 parts of radix rehmanniae praeparata, 4 parts to 9 parts of liquorice, 12 parts to 18 parts of semen cuscutae, 12 parts to 18 parts of eucommia ulmoides, 9 parts to 12 parts of cornu cervi degelatinatum, 4 parts to 9 parts of capsicum annuum, 9 parts to 12 parts of rhizoma curculiginis, 10 parts to 15 parts of herba epimedii, 9 parts to 12 parts of salvia miltiorrhiza, 9 parts to 12 parts of rhizoma cyperi, 9 parts to 12 parts of morinda officinalis, 9 parts to 12 parts of raspberries, 9 parts to 12 parts of polygonum multiflorum, 9 parts to 12 parts of dipsacus asperoides, 9 parts to 12 parts of glossy privet fruits, 9 parts to 12 parts of fructus psoraleae, 9 parts to 12 parts of astragalus membranaceus, 9 parts to 12 parts of Chinese yams and 12 parts to 18 parts of herba cistanche. According to the traditional Chinese medicine composition, the natural raw traditional Chinese medicinal materials are adopted, medicinal material sources are wide, cost is low, preparing is simple, the toxic and side effects are small, and the curative effect is remarkable.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of infertility.
Background technology
Infertility affects the able-bodied worldwide problem of men and women, and its sickness rate is very high.Infertility is many to be caused by common gynaecopathia, and minority also can be caused by systemic disease, and in addition, congenital physiological defect, namely so-called " five types of female sterility " also can cause infertile.Woman is matrimonial cohabitation more than 2 years after marriage, and syngamy function is normal, does not practise contraception and the person that do not become pregnant, and claims " primary infertility ".Except the infertility that congenital physiological defect causes, the infertility that other reason causes can use Drug therapy usually.
The traditional Chinese medical science is thought the generation of primary disease mainly because asthenia of renal qi, asthenia of essence and blood, stagnation of QI due to depression of the liver, stagnation of phlegm-damp etc. cause punching to appoint a QI and blood functional disorder, causes body can not become pregnant by consolidating semen.Therefore the suitable the kidney invigorating for the treatment of is soothing the liver, resolving depression and battalion, the punching that is in harmonious proportion is appointed
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of infertility.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of infertility, it comprises the material of following weight portion: Radix Codonopsis 12-18 part, Rhizoma Atractylodis Macrocephalae 9-12 part, Poria 9-12 part, Radix Paeoniae Alba 10-15 part, Radix Angelicae Sinensis 10-15 part, Rhizoma Chuanxiong 4-9 part, Radix Rehmanniae Preparata 10-15 part, Radix Glycyrrhizae 4-9 part, Semen Cuscutae 12-18 part, Cortex Eucommiae 12-18 part, Cornu Cervi Degelatinatum 9-12 part, Fructus Zanthoxyli 4-9 part, Rhizoma Curculiginis 9-12 part, Herba Epimedii 10-15 part, Radix Salviae Miltiorrhizae 9-12 part, Rhizoma Cyperi 9-12 part, Radix Morindae Officinalis 9-12 part, Fructus Rubi 9-12 part, Radix Polygoni Multiflori 9-12 part, Radix Dipsaci 9-12 part, Fructus Ligustri Lucidi 9-12 part, Fructus Psoraleae 9-12 part, Radix Astragali 9-12 part, Rhizoma Dioscoreae 9-12 part and Herba Cistanches 12-18 part.
Preferably, the Chinese medicine composition for the treatment of infertility of the present invention comprises the material of following weight portion: Radix Codonopsis 15 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 10 parts, Poria, the Radix Paeoniae Alba 12 parts, Radix Angelicae Sinensis 12 parts, Rhizoma Chuanxiong 5 parts, 12 parts, Radix Rehmanniae Preparata, 5 parts, Radix Glycyrrhizae, Semen Cuscutae 15 parts, the Cortex Eucommiae 15 parts, Cornu Cervi Degelatinatum 10 parts, Fructus Zanthoxyli 5 parts, Rhizoma Curculiginis 10 parts, Herba Epimedii 12 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Cyperi 10 parts, Radix Morindae Officinalis 10 parts, Fructus Rubi 10 parts, Radix Polygoni Multiflori 10 parts, Radix Dipsaci 10 parts, Fructus Ligustri Lucidi 10 parts, Fructus Psoraleae 10 parts, the Radix Astragali 10 parts, Rhizoma Dioscoreae 10 parts and Herba Cistanches 15 parts.
More preferably, the Chinese medicine composition for the treatment of infertility of the present invention also comprises the material of following weight portion: Elatostema oblohgifolium Fu. (Elatostema bodinier Levl) 12 parts, Radix et Rhizoma Iridis Sanguineae 10 parts, Herba Spilanthis Acmellae 8 parts, Herba seu Flos Convolvuli arvensis 6 parts, Herba Scutellariae Sessilifoliae 10 points, Herba Salviae Plebeiae 8 parts, fernleaf hedge bamboo 9 parts, five leaf potato 7 parts, Fructus Manglietiae fordianae 8 parts, Folium seu Radix Rubi Ichangensis 11 parts, cloud sedge 9 parts and Pelvetia siliquosa Tseng et C. F. Chang 8 parts.
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum or decoction.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment infertility, described compositions comprises the material of following weight portion: Radix Codonopsis 12-18 part, Rhizoma Atractylodis Macrocephalae 9-12 part, Poria 9-12 part, Radix Paeoniae Alba 10-15 part, Radix Angelicae Sinensis 10-15 part, Rhizoma Chuanxiong 4-9 part, Radix Rehmanniae Preparata 10-15 part, Radix Glycyrrhizae 4-9 part, Semen Cuscutae 12-18 part, Cortex Eucommiae 12-18 part, Cornu Cervi Degelatinatum 9-12 part, Fructus Zanthoxyli 4-9 part, Rhizoma Curculiginis 9-12 part, Herba Epimedii 10-15 part, Radix Salviae Miltiorrhizae 9-12 part, Rhizoma Cyperi 9-12 part, Radix Morindae Officinalis 9-12 part, Fructus Rubi 9-12 part, Radix Polygoni Multiflori 9-12 part, Radix Dipsaci 9-12 part, Fructus Ligustri Lucidi 9-12 part, Fructus Psoraleae 9-12 part, Radix Astragali 9-12 part, Rhizoma Dioscoreae 9-12 part and Herba Cistanches 12-18 part.
Preferably, described compositions comprises the material of following weight portion: Radix Codonopsis 15 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 10 parts, Poria, the Radix Paeoniae Alba 12 parts, Radix Angelicae Sinensis 12 parts, Rhizoma Chuanxiong 5 parts, 12 parts, Radix Rehmanniae Preparata, 5 parts, Radix Glycyrrhizae, Semen Cuscutae 15 parts, the Cortex Eucommiae 15 parts, Cornu Cervi Degelatinatum 10 parts, Fructus Zanthoxyli 5 parts, Rhizoma Curculiginis 10 parts, Herba Epimedii 12 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Cyperi 10 parts, Radix Morindae Officinalis 10 parts, Fructus Rubi 10 parts, Radix Polygoni Multiflori 10 parts, Radix Dipsaci 10 parts, Fructus Ligustri Lucidi 10 parts, Fructus Psoraleae 10 parts, the Radix Astragali 10 parts, Rhizoma Dioscoreae 10 parts and Herba Cistanches 15 parts.
More preferably, described compositions also comprises the material of following weight portion: Elatostema oblohgifolium Fu. (Elatostema bodinier Levl) 12 parts, Radix et Rhizoma Iridis Sanguineae 10 parts, Herba Spilanthis Acmellae 8 parts, Herba seu Flos Convolvuli arvensis 6 parts, Herba Scutellariae Sessilifoliae 10 points, Herba Salviae Plebeiae 8 parts, fernleaf hedge bamboo 9 parts, five leaf potato 7 parts, Fructus Manglietiae fordianae 8 parts, Folium seu Radix Rubi Ichangensis 11 parts, cloud sedge 9 parts and Pelvetia siliquosa Tseng et C. F. Chang 8 parts.
Most preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum or decoction.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 decoction of the present invention
Take Radix Codonopsis 15 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, 10 grams, Poria, the Radix Paeoniae Alba 12 grams, Radix Angelicae Sinensis 12 grams, Rhizoma Chuanxiong 5 grams, 12 grams, Radix Rehmanniae Preparata, 5 grams, Radix Glycyrrhizae, Semen Cuscutae 15 grams, the Cortex Eucommiae 15 grams, Cornu Cervi Degelatinatum 10 grams, Fructus Zanthoxyli 5 grams, Rhizoma Curculiginis 10 grams, Herba Epimedii 12 grams, Radix Salviae Miltiorrhizae 10 grams, Rhizoma Cyperi 10 grams, Radix Morindae Officinalis 10 grams, Fructus Rubi 10 grams, Radix Polygoni Multiflori 10 grams, Radix Dipsaci 10 grams, Fructus Ligustri Lucidi 10 grams, Fructus Psoraleae 10 grams, the Radix Astragali 10 grams, Rhizoma Dioscoreae 10 grams and Herba Cistanches 15 grams, add 5 liters, water, heating 5 hours under the condition of backflow, filter, make filtrate be cooled to room temperature, to obtain final product.
Embodiment 2 decoction of the present invention
Take Radix Codonopsis 15 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, 10 grams, Poria, the Radix Paeoniae Alba 12 grams, Radix Angelicae Sinensis 12 grams, Rhizoma Chuanxiong 5 grams, 12 grams, Radix Rehmanniae Preparata, 5 grams, Radix Glycyrrhizae, Semen Cuscutae 15 grams, the Cortex Eucommiae 15 grams, Cornu Cervi Degelatinatum 10 grams, Fructus Zanthoxyli 5 grams, Rhizoma Curculiginis 10 grams, Herba Epimedii 12 grams, Radix Salviae Miltiorrhizae 10 grams, Rhizoma Cyperi 10 grams, Radix Morindae Officinalis 10 grams, Fructus Rubi 10 grams, Radix Polygoni Multiflori 10 grams, Radix Dipsaci 10 grams, Fructus Ligustri Lucidi 10 grams, Fructus Psoraleae 10 grams, the Radix Astragali 10 grams, Rhizoma Dioscoreae 10 grams, Herba Cistanches 15 grams, Elatostema oblohgifolium Fu. (Elatostema bodinier Levl) 12 grams, Radix et Rhizoma Iridis Sanguineae 10 grams, Herba Spilanthis Acmellae 8 grams, Herba seu Flos Convolvuli arvensis 6 grams, Herba Scutellariae Sessilifoliae 10 points, Herba Salviae Plebeiae 8 grams, fernleaf hedge bamboo 9 grams, five leaf potatos 7 grams, Fructus Manglietiae fordianae 8 grams, Folium seu Radix Rubi Ichangensis 11 grams, cloud sedge 9 grams and Pelvetia siliquosa Tseng et C. F. Chang 8 grams, add 5 liters, water, heating 5 hours under the condition of backflow, filter, filtrate is made to be cooled to room temperature, obtain.
Experimental example
Diagnostic criteria:
Couple's sexual life was normal after marriage, more than 2 years persons of not becoming pregnant; Once become pregnant and pedestrian stream after marriage, but do not practise contraception later, again more than 2 years persons of not becoming pregnant; Once gave birth to a tire, for having two babies, man and wife had normal sexual life, does not practise contraception, more than 2 years infertile persons.Row hysterosalpingography confirms that obstruction of fallopian tube freely blocks or hydrops etc. simultaneously, or under laparoscopy, do hydrotubation, confirms that obstruction of fallopian tube is smooth or obstructed.
Selector close state diagnostic criteria patient 100 example, be divided into two groups, treatment group 1 be 50 example, age 22-35 year, average 30 years old; Treatment group 2 be 50 example, age 21-34 year, average 31 years old.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the decoction of preparation in embodiment 1 to treat, and menstrual cycle starts to take on the 1st, every day 3 times, oral 150 milliliters at every turn, continuously treatment 30 days.
Treatment group 2 uses the decoction of preparation in embodiment 2 to treat, and menstrual cycle starts to take on the 1st, every day 3 times, oral 150 milliliters at every turn, continuously treatment 30 days.
Statistical method
Utilize SPSS13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts x
2inspection, P < 0.05 represents that difference has statistical significance.
Criterion of therapeutical effect
After treatment terminates, follow up a case by regular visits to and judge curative effect in 1 year.
Recovery from illness: successful pregnancy after treatment, and give birth to.
Effective: through treatment after fallopian tube unobstructed, induced ovulation oneself success, or immunity factor oneself turn out cloudy, possessed condition of becoming pregnant, but not yet gestation; Or oneself is pregnant, because a variety of causes causes spontaneous abortion, artificial abortion and induced labor person; Once conceived that Aborter occurs was again pregnant, still nullipara in follow-up period.
Effective: after treatment, fallopian tube is substantially unobstructed, color ultrasound monitoring is even mature follicle, and endocrine disturbance's symptom takes a turn for the better to some extent, and gynecological inflammation alleviates to some extent.
Invalid: fail to dredge through treatment fallopian tube, or block again after dredging, endocrine disturbance is corrected, and induced ovulation produces drug resistance person.
Result
Find through treatment: in treatment group 1, recovery from illness 20 example, effective 11 examples, effective 9 examples, invalid 10 examples, total effective rate is 80%; In treatment group 2, recovery from illness 26 example, effective 14 examples, effective 7 examples, invalid 3 examples, total effective rate is 94%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).
Claims (8)
1. treat the Chinese medicine composition of infertility for one kind, it is characterized in that, it comprises the material of following weight portion: Radix Codonopsis 12-18 part, Rhizoma Atractylodis Macrocephalae 9-12 part, Poria 9-12 part, Radix Paeoniae Alba 10-15 part, Radix Angelicae Sinensis 10-15 part, Rhizoma Chuanxiong 4-9 part, Radix Rehmanniae Preparata 10-15 part, Radix Glycyrrhizae 4-9 part, Semen Cuscutae 12-18 part, Cortex Eucommiae 12-18 part, Cornu Cervi Degelatinatum 9-12 part, Fructus Zanthoxyli 4-9 part, Rhizoma Curculiginis 9-12 part, Herba Epimedii 10-15 part, Radix Salviae Miltiorrhizae 9-12 part, Rhizoma Cyperi 9-12 part, Radix Morindae Officinalis 9-12 part, Fructus Rubi 9-12 part, Radix Polygoni Multiflori 9-12 part, Radix Dipsaci 9-12 part, Fructus Ligustri Lucidi 9-12 part, Fructus Psoraleae 9-12 part, Radix Astragali 9-12 part, Rhizoma Dioscoreae 9-12 part and Herba Cistanches 12-18 part.
2. the Chinese medicine composition for the treatment of infertility according to claim 1, it is characterized in that, it comprises the material of following weight portion: Radix Codonopsis 15 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 10 parts, Poria, the Radix Paeoniae Alba 12 parts, Radix Angelicae Sinensis 12 parts, Rhizoma Chuanxiong 5 parts, 12 parts, Radix Rehmanniae Preparata, 5 parts, Radix Glycyrrhizae, Semen Cuscutae 15 parts, the Cortex Eucommiae 15 parts, Cornu Cervi Degelatinatum 10 parts, Fructus Zanthoxyli 5 parts, Rhizoma Curculiginis 10 parts, Herba Epimedii 12 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Cyperi 10 parts, Radix Morindae Officinalis 10 parts, Fructus Rubi 10 parts, Radix Polygoni Multiflori 10 parts, Radix Dipsaci 10 parts, Fructus Ligustri Lucidi 10 parts, Fructus Psoraleae 10 parts, the Radix Astragali 10 parts, Rhizoma Dioscoreae 10 parts and Herba Cistanches 15 parts.
3. the Chinese medicine composition for the treatment of infertility according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Elatostema oblohgifolium Fu. (Elatostema bodinier Levl) 12 parts, Radix et Rhizoma Iridis Sanguineae 10 parts, Herba Spilanthis Acmellae 8 parts, Herba seu Flos Convolvuli arvensis 6 parts, Herba Scutellariae Sessilifoliae 10 points, Herba Salviae Plebeiae 8 parts, fernleaf hedge bamboo 9 parts, five leaf potato 7 parts, Fructus Manglietiae fordianae 8 parts, Folium seu Radix Rubi Ichangensis 11 parts, cloud sedge 9 parts and Pelvetia siliquosa Tseng et C. F. Chang 8 parts.
4. the Chinese medicine composition for the treatment of infertility according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, unguentum or decoction.
5. the purposes of compositions in the Chinese medicine of preparation treatment infertility, it is characterized in that, described compositions comprises the material of following weight portion: Radix Codonopsis 12-18 part, Rhizoma Atractylodis Macrocephalae 9-12 part, Poria 9-12 part, Radix Paeoniae Alba 10-15 part, Radix Angelicae Sinensis 10-15 part, Rhizoma Chuanxiong 4-9 part, Radix Rehmanniae Preparata 10-15 part, Radix Glycyrrhizae 4-9 part, Semen Cuscutae 12-18 part, Cortex Eucommiae 12-18 part, Cornu Cervi Degelatinatum 9-12 part, Fructus Zanthoxyli 4-9 part, Rhizoma Curculiginis 9-12 part, Herba Epimedii 10-15 part, Radix Salviae Miltiorrhizae 9-12 part, Rhizoma Cyperi 9-12 part, Radix Morindae Officinalis 9-12 part, Fructus Rubi 9-12 part, Radix Polygoni Multiflori 9-12 part, Radix Dipsaci 9-12 part, Fructus Ligustri Lucidi 9-12 part, Fructus Psoraleae 9-12 part, Radix Astragali 9-12 part, Rhizoma Dioscoreae 9-12 part and Herba Cistanches 12-18 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Radix Codonopsis 15 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 10 parts, Poria, the Radix Paeoniae Alba 12 parts, Radix Angelicae Sinensis 12 parts, Rhizoma Chuanxiong 5 parts, 12 parts, Radix Rehmanniae Preparata, 5 parts, Radix Glycyrrhizae, Semen Cuscutae 15 parts, the Cortex Eucommiae 15 parts, Cornu Cervi Degelatinatum 10 parts, Fructus Zanthoxyli 5 parts, Rhizoma Curculiginis 10 parts, Herba Epimedii 12 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Cyperi 10 parts, Radix Morindae Officinalis 10 parts, Fructus Rubi 10 parts, Radix Polygoni Multiflori 10 parts, Radix Dipsaci 10 parts, Fructus Ligustri Lucidi 10 parts, Fructus Psoraleae 10 parts, the Radix Astragali 10 parts, Rhizoma Dioscoreae 10 parts and Herba Cistanches 15 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Elatostema oblohgifolium Fu. (Elatostema bodinier Levl) 12 parts, Radix et Rhizoma Iridis Sanguineae 10 parts, Herba Spilanthis Acmellae 8 parts, Herba seu Flos Convolvuli arvensis 6 parts, Herba Scutellariae Sessilifoliae 10 points, Herba Salviae Plebeiae 8 parts, fernleaf hedge bamboo 9 parts, five leaf potato 7 parts, Fructus Manglietiae fordianae 8 parts, Folium seu Radix Rubi Ichangensis 11 parts, cloud sedge 9 parts and Pelvetia siliquosa Tseng et C. F. Chang 8 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, unguentum or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510540293.7A CN105055781A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating female infertility |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510540293.7A CN105055781A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating female infertility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105055781A true CN105055781A (en) | 2015-11-18 |
Family
ID=54485458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510540293.7A Pending CN105055781A (en) | 2015-08-28 | 2015-08-28 | Traditional Chinese medicine composition for treating female infertility |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105055781A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107802733A (en) * | 2017-12-01 | 2018-03-16 | 上海中医药大学附属曙光医院 | Tire Chinese medicine composition and its application are educated in a kind of kidney tonifying |
| CN108324821A (en) * | 2018-04-19 | 2018-07-27 | 山东中医药大学 | It is a kind of that there is the Chinese medicine composition for inducing follicular development effect and its application |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1356123A (en) * | 2001-08-16 | 2002-07-03 | 赵西铭 | Medicine for treating female acyesis |
| CN1628840A (en) * | 2004-08-17 | 2005-06-22 | 石春荣 | Medicine for promoting ovulation and aiding pregnancy |
| CN103893464A (en) * | 2012-12-26 | 2014-07-02 | 刘药石 | Traditional Chinese medicine preparation used for adjusting menstrual period and promoting pregnancy |
| CN104758639A (en) * | 2015-04-30 | 2015-07-08 | 楼基祥 | Follicle regeneration and development promoting Chinese herba preparation for treating female infertility |
| CN104758755A (en) * | 2015-04-30 | 2015-07-08 | 楼基祥 | Ovulation induction traditional Chinese medicine medicament for treating female infertility |
-
2015
- 2015-08-28 CN CN201510540293.7A patent/CN105055781A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1356123A (en) * | 2001-08-16 | 2002-07-03 | 赵西铭 | Medicine for treating female acyesis |
| CN1628840A (en) * | 2004-08-17 | 2005-06-22 | 石春荣 | Medicine for promoting ovulation and aiding pregnancy |
| CN103893464A (en) * | 2012-12-26 | 2014-07-02 | 刘药石 | Traditional Chinese medicine preparation used for adjusting menstrual period and promoting pregnancy |
| CN104758639A (en) * | 2015-04-30 | 2015-07-08 | 楼基祥 | Follicle regeneration and development promoting Chinese herba preparation for treating female infertility |
| CN104758755A (en) * | 2015-04-30 | 2015-07-08 | 楼基祥 | Ovulation induction traditional Chinese medicine medicament for treating female infertility |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107802733A (en) * | 2017-12-01 | 2018-03-16 | 上海中医药大学附属曙光医院 | Tire Chinese medicine composition and its application are educated in a kind of kidney tonifying |
| CN107802733B (en) * | 2017-12-01 | 2020-12-15 | 上海中医药大学附属曙光医院 | Kidney-tonifying and fetus-cultivating traditional Chinese medicine composition and application thereof |
| CN108324821A (en) * | 2018-04-19 | 2018-07-27 | 山东中医药大学 | It is a kind of that there is the Chinese medicine composition for inducing follicular development effect and its application |
| CN108324821B (en) * | 2018-04-19 | 2021-05-18 | 山东中医药大学 | Traditional Chinese medicine composition with effect of inducing follicular development and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352776B (en) | A kind of hypomenorrhia for the treatment of causes infertile Chinese medicine preparation and preparation method thereof | |
| CN103316284B (en) | Cholelithiasis treatment drug | |
| CN104623502A (en) | Traditional Chinese medicine composition for calming fetus | |
| CN105214044A (en) | A kind of Chinese medicine composition for nursing one's health female body health | |
| CN103432545A (en) | Medicament for allaying fever of child and preparation method thereof | |
| CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
| CN101757498B (en) | Traditional Chinese medicine for treating pregnancy-induced hypertension postpartum proteinuria | |
| CN104758639A (en) | Follicle regeneration and development promoting Chinese herba preparation for treating female infertility | |
| CN104758755A (en) | Ovulation induction traditional Chinese medicine medicament for treating female infertility | |
| CN104958448A (en) | Medicine for treating puerperal infection | |
| CN105055781A (en) | Traditional Chinese medicine composition for treating female infertility | |
| CN102657809B (en) | Medicament for treating oligohydramnios | |
| CN103860882A (en) | Medicinal preparation for treating chronic cervicitis | |
| CN105963644A (en) | Formula for treating hyperplasia of mammary glands | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN105288538A (en) | Application of medicine composition for preparing medicine for treating amenorrhea | |
| CN104161971A (en) | Traditional Chinese medicine composition for treating preceded menorrhea | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN103566219A (en) | Traditional Chinese medicine composition for treating cold | |
| CN103251893A (en) | Traditional Chinese medicine composition for treating male sterility | |
| CN102988890A (en) | Pure Chinese medicine preparation for treating chloasma | |
| CN102228613B (en) | Chinese patent medicine for treating tinea capitis | |
| CN102872277B (en) | Medicine for treating habitual abortion | |
| CN105056139A (en) | Chinese herbal preparation for treating female infertility |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151118 |